Illinois Municipal Retirement Fund Has $13.06 Million Stake in CVS Health Corporation $CVS

Illinois Municipal Retirement Fund lifted its stake in CVS Health Corporation (NYSE:CVSFree Report) by 6.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 173,275 shares of the pharmacy operator’s stock after purchasing an additional 11,030 shares during the period. Illinois Municipal Retirement Fund’s holdings in CVS Health were worth $13,063,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CVS. Avion Wealth raised its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. Corundum Trust Company INC bought a new stake in CVS Health during the 3rd quarter worth about $29,000. Harbor Asset Planning Inc. bought a new position in shares of CVS Health in the 2nd quarter valued at about $30,000. Finally, Front Row Advisors LLC grew its position in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on CVS shares. Argus reduced their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. JPMorgan Chase & Co. raised their price target on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Bank of America reduced their target price on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. Finally, Morgan Stanley upped their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.82.

View Our Latest Analysis on CVS

CVS Health Stock Up 1.2%

Shares of CVS Health stock opened at $77.93 on Friday. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The company has a market capitalization of $99.14 billion, a P/E ratio of 56.47, a price-to-earnings-growth ratio of 0.71 and a beta of 0.50. The business has a 50-day moving average of $78.58 and a two-hundred day moving average of $75.99.

CVS Health (NYSE:CVSGet Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.CVS Health’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is 700.00%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Read More

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.